Article

USABA becomes finalist for excellence award

Colorado Springs, CO-The El Pomar Foundation has named the United States Association of Blind Athletes as a finalist in the foundation's Awards for Excellence in the Sports and Recreation category. The awards program honors outstanding achievement of Colorado's nonprofit organizations. Each year three finalists are selected in 11 categories. Winners will be named in November.

Colorado Springs, CO-The El Pomar Foundation has named the United States Association of Blind Athletes as a finalist in the foundation's Awards for Excellence in the Sports and Recreation category. The awards program honors outstanding achievement of Colorado's nonprofit organizations. Each year three finalists are selected in 11 categories. Winners will be named in November.

"It is truly an honor to be named a finalist for El Pomar's Awards for Excellence," said Kevin Szott, president of USABA's board of directors. "It is a tribute to the impact made by our athletes, coaches, volunteers, and staff."

Last year nearly 300 blind and visually impaired athletes and an additional 200 support staff came from across the globe for the week-long International Blind Sports Association World Youth Championships in Colorado Springs. The USABA hosted the event.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.